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ABSTRACT
Relapse after initially successful treatment is a signiﬁcant problem facing the treatment of opioid dependence. Evidence
suggests craving elicited by re-exposure to drug cues may precipitate relapse. Attempts to identify neural biomarkers of
cue-elicited craving have yielded inconsistent ﬁndings. We aimed to apply a novel continuous functional magnetic
resonance imaging technique to follow the minute-to-minute evolution of brain responses, which correlate with the
waxing and waning of craving. Newly detoxiﬁedmale opioid-dependent patients and healthy control participants attended
two separate, counterbalanced, functional magnetic resonance imaging scanning sessions during which they viewed a
10-minute video (drug cue or neutral cue) followed by 5 minutes of ﬁxation. Participants rated the intensity of their crav-
ing throughout each session. We hypothesized that subcortical/ventral prefrontal cortex (PFC) regions and dorsal PFC re-
gions would show different associations with craving reﬂecting their putative roles in appetitive processing versus cognitive
control. Compared with controls, drug cue (minus neutral cue) video recruited the left amygdala and was temporally cor-
related with craving. In contrast, dorsal anterior cingulate blood-oxygen-level-dependent signal time course was higher
than controls only during a period after cue exposure when craving levels were declining. Against expectations, neither
the ventral striatum nor ventral PFC was signiﬁcantly recruited by drug cue exposure. Findings suggest that the amygdala
has a central role in craving, whereas the dorsal anterior cingulate may control craving in treatment-seeking patients.
Time course analysis yielded new insights into the neural substrates of craving that could objectively validate development
of psychological and pharmacological approaches to sustained abstinence.
Keywords addiction, craving, cues, fMRI, heroin, opioid.
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INTRODUCTION
Neural and psychological responses to stimuli or contexts
previously associated with drug reward (i.e. drug cues)
play a signiﬁcant role in drug dependence (Lubman,
Yucel, & Pantelis 2004; Epstein et al. 2009). Conditioning
mechanisms increase the incentive value of these cues,
creating powerful secondary reinforcers that can capture
attention and elicit craving (Tiffany & Wray 2012), and
contribute to further drug seeking and drug taking.
Consistent with this notion, several studies have reported
that craving measured before or during treatment can
predict subsequent relapse (Weiss et al. 2003; McHugh
et al. 2014), whilst ‘real-time’ craving and cue exposure
have been shown to immediately precede relapse and
drug use (Epstein et al. 2009; Moore et al. 2014; Fatseas
et al. 2015). Functional magnetic resonance imaging
(fMRI) studies have attempted to identify brain systems
that mediate cue-elicited craving (Zijlstra et al. 2009; Li
et al. 2012; Jasinska et al. 2014). Two recent meta-
analyses of these studies (Chase et al. 2011; Kuhn &
Gallinat 2011) report reliable activation to drug cues
within regions including the amygdala and ventral
striatum, which are important for processing reward-
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related stimuli and motivation (Haber & Knutson 2010),
and medial prefrontal regions. These include the ventral
medial prefrontal cortex (VmPFC) (Chase et al. 2011),
which is involved in the representation of reward value
and reward-related decision making (Elliott, Agnew, &
Deakin 2008; Grabenhorst & Rolls 2011), and the ante-
rior cingulate cortex (Kuhn & Gallinat 2011), which is
important for reward and error-related behavioural
and cognitive control (Shenhav, Botvinick, & Cohen
2013). Although there are some consistencies in the re-
gions that are activated by drug cues, there is little evi-
dence that any reliably correlate with craving (Tiffany &
Wray 2012). This suggests the typical design of cue-
elicited craving studies, that measure brief presentations
of drug-related images interspersed with neutral control
images, identify immediate brain responses to drug cues,
rather than craving per se. Video imagery of drug-
related activities provides contextually richer and more
realistic cues that better model real-world exposure
and elicit strong craving responses (Childress et al.
1999; Tong, Bovbjerg, & Erblich 2007). Videos have
been extensively used to follow psychophysiological re-
sponses to craving although this has been limited to
box-car on-off fMRI designs through the lack of
techniques or tradition for following blood-oxygen-
level-dependent (BOLD) responses over minutes. We
borrowed pharmaco-MRI methods developed to follow
and localize the action of drugs on the CNS, to follow
the effect of sustained craving elicited by video cues, in
hypothesized regions of interest. We reasoned that this
approach could capitalize on the video mode of drug
cue delivery, providing time course fMRI information
for investigation of how psychological variables relate
to brain response over time. We applied this approach
in recently abstinent individuals with opioid dependence
(OD), to better delineate brain responses related to the
experience of craving over a period of cue exposure. We ad-
ditionally investigated brain response for a period after cue
exposure to gain insights into regions that may be involved
in cognitive/behavioural control. Although videos have
previously been used in fMRI studies of substance depen-
dence, to our knowledge, dynamic brain responses to these
cues have not previously been explored.
In recovering dependent individuals, brain responses
to drug cues may reﬂect not only craving-related
activity but also attempts to control craving (Goldstein
& Volkow 2011). This may explain why some partici-
pants in previous cue exposure studies have not
reported signiﬁcant overall changes in craving scores
(Zijlstra et al. 2009; Wang et al. 2011). Time course
information derived dynamically across video stimuli
could help distinguish brieﬂy induced craving and
subsequent control at a neuronal level, thereby
disambiguating distinct processes that may have been
compounded in previous studies. We hypothesized that
early development of craving would be associated with
activation of amygdala, ventral striatum and ventral
medial prefrontal regions involved in processing reward
value and incentive motivation. In our treatment-
seeking sample, with long-term goals of abstinence, we
further hypothesized that response in the dorsal anterior
cingulate cortex would develop both during and after
the video as subjective craving decreased, reﬂecting
conscious control mechanisms.
METHODS AND MATERIALS
Participants
Opioid-dependent individuals (n = 18)
This study was approved by the NHS Research Ethics
Committee. Participants with OD were recruited from
a residential detoxiﬁcation unit within Greater
Manchester (see Table 1 for demographic information).
Treatment involved a 4-week residential stay with a
10-day methadone stabilization and reduction, followed
by 10 days of lofexidine treatment, an alpha-2 adrener-
gic receptor agonist used to treat opioid withdrawal
symptoms. Participants took part in the study during
the last week of their residential stay when they were
opioid free (conﬁrmed by urine drug screen). Lofexidine
was extended at low doses for participants still
experiencing withdrawal symptoms during this ﬁnal
week, and some ODs were receiving other psychoactive
medications as indicated by Supporting Information
Table S1. The OD group was recruited according to
the following inclusion criteria: male, aged 18–55;
current DSM IV heroin dependence (the majority of
patients also met criteria for current or past dependence
on other substances; Table 1); no history of serious
psychiatric, neurological or physical illness; no contrain-
dications for MRI; and IQ of ≥85 [determined using the
Wechsler Test of Adult Reading (Holdnack 2001)].
Participants were identiﬁed and approached by mem-
bers of the clinical team on the basis of detailed physical
and mental health assessments on admission to the
unit. All participants meeting the inclusion criteria were
approached to take part in the study. A total of 39
patients were enrolled in the craving study; however,
19 were discharged from the unit before any testing
could take place (mainly self-discharge or early
discharge due to use of prohibited substances). Twenty
patients were scanned as part of the study, although
two were excluded from analysis because of excessive
movement (see Preprocessing section for further details),
leaving n = 18 who were included in analysis.
Handedness was assessed with the Edinburgh Handed-
ness Inventory (Oldﬁeld 1971).
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Healthy controls (n = 20)
Healthy controls (HCs) were recruited who were familiar
with graphic scenes of drug use because of occupational
experience (e.g. drug treatment workers and other health
professionals). The HC group met the same inclusion
criteria outlined previously and additionally had no
current or past history of drug dependence or misuse
(except nicotine) and had never used heroin in their life-
time. No healthy volunteers were receiving psychoactive
medications. Participants were screened with the Mini
International Neuropsychiatric Interview (Sheehan
et al. 1998), Wechsler Test of Adult Reading and
Edinburgh Handedness Inventory.
All participants provided written consent and were
paid for their participation with vouchers.
Procedures
Participants attended two separate, counterbalanced
sessions. Patients were scanned in the last week of their
residential stay when they were opioid free. On each
occasion, participants underwent fMRI, once whilst view-
ing a 10-minute heroin video (drug cue session) and once
whilst viewing a 10-minute video containing scenes
matched for visual complexity but lacking emotionally
arousing content (neutral session). Videos were preceded
and followed by 5 minutes of ﬁxation (Fig. 1). Images were
presented using E-PRIME (Psychology Software Tools, Inc,
Sharpsburg, USA) (version 2.0).
Measures
Participants were presented with Likert-like subjective
rating scales throughout the scanning session. Partici-
pants were prompted to respond by a screen displaying
the following text ‘do you feel you are …’, which was
presented for 3 seconds before slides stating ‘Craving?’,
‘Withdrawing?’, ‘Anxious?’ or ‘High?’, were presented
for 4 seconds along with the following scale: 1 (not all),
2 (slightly), 3 (moderately) and 4 (extremely).
Table 1 Demographic and clinical information of OD (n = 18) and HC (n = 20) groups included in the analysis.
OD group HC group p-value
Age 34.8 (6.3) 31.6 (7.2) 0.15
IQ 103.1.9 (7.7) 114.1 (4.7) <0.05
Years of education 11.5 (2.2) 16.5 (3.3) <0.05
No. of right handers 16 (89 percent) 18 (90 percent) 0.91
No. of smokers (nicotine) 13 (72 percent) 9 (45 percent) 0.09
Clinical Variables for OD group
Years of opioid dependence 12.8 (7.7) —
Average daily opioid use (g) 0.7 (0.6) —
Age of ﬁrst use (years) 20.3 (4.3)
No. who primarily smoke/inject/
or use both methods for heroin administration
5 (28 percent)/5 (28 percent)/
8 (44 percent)
—
No. of OD group with current/past history of: —
Alcohol dependence 7 (39 percent) —
Cocaine dependence 7 (39 percent)
Amphetamine dependence 1 (6 percent) —
Benzodiazepine dependence 3 (17 percent) —
Heroin dependence only (except nicotine) 6 (33 percent) —
Age, IQ, years of education, years of dependence, average daily amount used and age of ﬁrst use expressed as mean and standard deviation (in brackets).
All other variables expressed as frequency and proportion of group (in brackets). P-values taken from independent t-tests for continuous data and chi-
squared tests for frequency data.
Figure 1 Diagram illustrating 1-
minute time-bins for the drug cue
and neutral sessions. The 480 scans
were divided into 1 minute time-bins.
T0 was the 5th minute of the pre-
video baseline, T1–T10 were the
time-bins acquired during the video
and T11-T15 were the post-video
time-bins. The arrows indicate the
time points of the presentation of
the Likert-like subjective rating scales
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Participants responded via a button box. The scales were
presented at 3-minute intervals in each session (Fig. 1)
Behavioural data
Mixed ANOVAs were carried out for each of the four
subjective rating scales with time of rating (six levels
including a pre-video baseline rating, three during the
video and two post-video ratings) and session (drug cue,
neutral) as within-subject factors and group (HC, OD)
as the between-subject factor. Session order was included
as a covariate. The pre-video rating taken during the last
minute of the baseline period (T0) was used as the pre-
video baseline rating. A Greenhouse-Geisser correction
was applied when Mauchley’s assumption of sphericity
was violated. Ratings from one HC were not included as
the participant could not see the rating scales.
Scanning and analysis
Whole brain T2* weighted images were acquired on a 3
Tesla Philips Achieva scanner with single shot, multi-slice
echo planar (EPI) pulse sequence. Each volume com-
prised 34 contiguous axial slices (TR = 2.5 s, TE = 35 ms,
96 × 96 matrix, in-plane voxel size 3.0 mm × 3.0 mm,
slice thickness 3.5 mm). A high-resolution T1-weighted
structural image was also acquired for each participant
for coregistration during preprocessing and to exclude
any structural abnormality.
Preprocessing
Functional data were analysed using statistical parametric
mapping (SPM8; The Wellcome Department of Cognitive
Neurology, London, UK) running in MATLAB (Matlab,
R2012a; Mathworks, Natick, Massachusetts, U.S.A.). Func-
tional images were realigned and coregistered with the T1
structural image before normalization of the functional im-
ages into standard space was carried out using the uniﬁed
segmentation approach (Ashburner & Friston 2005). Nor-
malized images were smoothed using an 8-mm Gaussian
kernel. The smoothed functional images of the participants
who moved more than 1 voxel were repaired by an interpo-
lationmethod using the artefact repair toolbox (http://cibsr.
stanford.edu/tools/ArtRepair/ArtRepair.htm). Two ODs
with excessive movement were excluded (>10 percent vol-
umes needing repairing). Eighteen ODs and 20 HCs were
entered into subsequent analyses.
First-level analysis
For both the drug cue and the neutral session, data were
acquired continuously for 20 minutes (5 minutes before
the start of each video to allow participants to acclimatize
to the scanner environment, 10 minutes during
presentation of the video and an additional 5 minutes
after the end of the video) (Fig. 1). The resultant 480 ac-
quired scans were divided into 1-minute time-bins (20
time-bins in total). The 5th minute of the pre-video base-
line was treated as the baseline time-bin T0, with each
subsequent time-bin (T1–15) compared with T0 using re-
gression analysis within a general linear model frame-
work. The exact shape of the signal of interest was
unknown; therefore, no high-pass ﬁlter was used. The
neutral session averages were subtracted from the time
equivalent drug cue session averages, resulting in ‘drug
cue session–neutral session’ contrast images.
Region-of-interest analysis
A region-of-interest (ROI) approach was used to extract
time course signals from key brain regions involved in
drug cue reactivity based on recent meta-analyses (Chase
et al. 2011; Kuhn & Gallinat 2011). These composed of
spheres of 7-mm radius centred around the bilateral
ventral striatum, amygdala and VmPFC, coordinates
from Chase et al. (2011), and anterior cingulate cortex,
coordinates from Kuhn & Gallinat (2011), as displayed
in Fig. 3. Mean drug cue-neutral session contrast esti-
mates were extracted from each of the six ROIs using
the Easy ROI toolbox implemented in SPM (http://www.
sbirc.ed.ac.uk/LCL/LCL_M1.html) and entered into mixed
ANOVAs in SPSS (version 20) to investigate effects of time
and group on drug cue-neutral session BOLD signal.
Investigations were carried out for the whole session (T0
to T15) and for the video time-bins (T1–T10) and post-
video time-bins separately (T11 to T15) with session order
included as a covariate. A Greenhouse-Geisser correction
was applied when Mauchley’s assumption of sphericity
was violated. A Bonferroni correction for the six separate
ROIs results in a signiﬁcance value of p < 0.008 for this
analysis. However, this is a conservative approach, which
may result in false negatives. Results are therefore
reported signiﬁcant at p < 0.05 with results surviving
Bonferroni correction highlighted.
ROI BOLD signal time course and subjective rating time
course temporal correlation analysis
In participants reporting a subjective rating change in
response to the drug cue session, we investigated whether
their subjective rating time course was temporally
correlated with fMRI signal in the ROIs. Analyses were
restricted to subjective ratings and ROI BOLD signal time
courses, demonstrating signiﬁcant effects in the ANOVAs.
Before correlations were carried out, the pre-video base-
line subjective rating was subtracted from each video
and post-video rating for each session. The neutral
session ratings were then subtracted from the drug cue
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session ratings. This was to ensure both the fMRI and
subjective rating data reﬂected drug cue session changes
from baseline minus neutral session changes from base-
line (fMRI data already in this format after ﬁrst-level
analysis). Finally, the fMRI BOLD signal data were aver-
aged over 3-minute intervals to reﬂect the 3-minute in-
terval of subjective rating presentation during each
session. Correlational analyses were carried out between
each individual’s subjective rating and ROI BOLD signal
time courses using Pearson’s product moment correla-
tion coefﬁcient. Resultant correlation coefﬁcients were
Fisher’s z-transformed and entered into one-sample t-
tests to determine group level signiﬁcance.
RESULTS
Subjective ratings
Craving
All main effects and two-way interactions were signiﬁ-
cant (p < 0.001) as was the time × session × group inter-
action [F(3.54, 123.93) = 7.54, p < 0.001]. Subjective
craving increased signiﬁcantly during the drug session
in the OD group only as shown in Fig. 2.
Anxiety
No signiﬁcant main effect of time or session was
revealed, although an overall main effect of group was
found [F(1,34) = 23.45, p < 0.001] indicating higher
anxiety in the OD than HC group (Fig. 2). A
signiﬁcant time × session interaction was found
[F(3.53, 119.97) = 2.87, p = 0.03], but no three-way
interaction (p > 0.05); anxiety increased in both the
OD and HC groups during the craving compared with
neutral videos.
High
No signiﬁcant main effects or interactions were found
(Fig. 2).
Withdrawal
There was a signiﬁcant main effect of group [F(1,
34) = 10.47, p = 0.003], but no other signiﬁcant main
effects or interactions. Higher withdrawal symptoms
were reported in the OD group compared with HC group
throughout both sessions (Fig. 2).
Figure 2 Subjective ratings taken during both the drug cue and neutral session in ODs (n = 18) and HCs (n = 20). Ratings were taken every
3 minutes throughout each session: 1 (not at all), 2 (slight), 3 (moderate) and 4 (extreme). The video started at 0 minute and ended at 10 minutes
(grey bar). Error bars show standard error of the mean (SEM)
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Effects of group and time on ROI BOLD signal
Signiﬁcant effects were observed only in the left amygdala
and dACC (see Supporting Information Tables S2–S4 for
F-values and p-values for all of the regions of interest).
Within the left amygdala, there was an overall main ef-
fect of group (OD > HC, p = 0.014). Focusing on the
video period only, there was a signiﬁcant time × group in-
teraction (p = 0.017) and a signiﬁcant effect of group sur-
viving Bonferroni correction for the six ROIs (p = 0.007).
Figure 3 shows that these effects were due to amygdala
BOLD signal increasing during the video in the OD group
only. There was a signiﬁcant effect of time (p = 0.041)
and time × group interaction (p = 0.018) during the
5-minute period after the end of the video. The effect of
group was no longer signiﬁcant during this period.
Figure 3 illustrates that these effects were due to BOLD
signal dropping in the OD group only after the end of
the video session.
Within the dACC, there was a signiﬁcant main effect
of time for the entire drug cue-neutral session time
course, surviving Bonferroni correction for the six ROIs
(p = 0.004). There was no time × group interaction,
suggesting signiﬁcant time course effects in both
groups. dACC BOLD signal within the OD group was
signiﬁcantly higher than in the HC group within the
post-video period only (p = 0.046). Figure 3 illustrates
that this effect is due to sustained recruitment of the
dACC after the end of the video session in the OD group
only.
There were no main effects or interactions for the four
other ROIs examined.
Figure 3 Regions of interest and average BOLD signal time course of each region. Time courses show the BOLD signal difference between
drug cue-neutral session in the bilateral amygdala, dorsal anterior cingulate and ventral medial prefrontal cortex. The videos were displayed from
0 to 10 minutes (grey bar). The last 5 minutes are the post-video period. The solid blue bars demonstrate the average time course of the OD
group (n = 18), and the red dotted line shows the average time course of the HC group (n = 20). Error bars show standard error of the mean
(SEM)
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Temporal correlations between subjective ratings and
ROI BOLD signal time courses
Analyses were restricted to craving/anxiety ratings and
amygdala/dACC ROIs in the OD group, and anxiety
ratings and dACC in the HC group, as these were the only
ratings/ROI BOLD signal time courses that were signiﬁ-
cant in the ANOVAs. As some participants did not report
a drug cue-neutral session change in their subjective
ratings (5 in OD group for craving, 4 in OD group for
anxiety and 10 in HC group for anxiety), subjective
rating-BOLD signal correlations could not be conducted
for these individuals for these rating scales.
The only correlation that was signiﬁcant was between
craving and left amygdala time courses in the OD group
[mean (SD) Fisher’s z-score = 0.44(66), t(12)=2.40,
p = 0.034) (Table 2).
DISCUSSION
In this study, we demonstrated that a drug cue video
increased craving in 13 of 18 recently detoxiﬁed opioid-
dependent participants, with a time course that
correlated with BOLD signal time course within the left
amygdala but not the dACC. Peak amygdala response
occurred during the drug cue video in the OD group,
whereas dACC BOLD responses peaked in the 5 minutes
following the drug cue video (when craving levels were
decreasing). Although anxiety ratings increased in
response to the drug cue video, no correlations were
found with either the amygdala or dACC. Against expec-
tations, the ventral striatum was not recruited by the
drug cue paradigm.
The amygdala and craving
The signiﬁcant correlation between amygdala BOLD
signal and the time course of craving (but not anxiety)
suggests the amygdala has a key role in the generation
of cue-elicited craving. This ﬁnding is in agreement with
evidence demonstrating the amygdala to be important
for Pavlovian-conditioned behaviour and motivation
(Janak & Tye 2015). Preclinical ﬁndings demonstrate
both the basolateral and central amygdala to be crucial
for generating drug-seeking responses to drug cues (Li
et al. 2008; Buffalari & See 2010). Human fMRI studies
similarly report amygdala activation in response to
heroin cues (Langleben et al. 2008; Mei, Zhang, & Xiao
2010; Li et al. 2012; Langleben et al. 2014), and pharma-
cological agents used to manage OD attenuate both
amygdala activation and craving (Langleben et al.
2008; Mei et al. 2010; Langleben et al. 2014). However,
whilst one recent meta-analysis of cue-elicited craving
paradigms did identify an association between amygdala
activation and subjective craving (Chase et al. 2011),
another meta-analysis did not (Kuhn & Gallinat 2011).
One potential reason for this discrepancy may relate
to differences in the methodology employed to examine
brain-craving relationships. Traditional fMRI designs
correlate average magnitude of BOLD signal during cue
presentation with mean craving scores. This approach
may be problematic given the non-quantitative nature
of BOLD, and the variation of craving over time. The
current time course study allowed us to investigate how
the shape of the BOLD signal related to subjective craving
over time. Unlike a number of previous studies, we did
observe a signiﬁcant correlation, suggesting that this
approach may be more reliable, and/or sensitive, in
detecting a biomarker of subjective craving.
The effects within the amygdala were unilateral,
possibly suggesting a left-sided laterality for craving. Pre-
vious meta-analyses of cue-elicited craving studies have
demonstrated a different lateralisation dependent upon
the substance of dependence (Kuhn & Gallinat 2011) or
the contrast investigated (Chase et al. 2011). Study
design may also inﬂuence lateralisation, as the left amyg-
dala is more commonly recruited in block designs rather
than event-related designs (Sergerie, Chochol, & Armony
2008), which may reﬂect different temporal dynamics
(i.e. the right amygdala rapidly and automatically detects
emotional stimuli, whilst the left amygdala engages in a
more sustained evaluation) (Wright et al. 2001; Sergerie
et al. 2008). Our sustained video stimulus would thus
plausibly lead to a left-lateralised response.
Dorsal ACC and craving
The dorsal ACC region is involved in both affective
processing and higher order cognitive and behavioural
control (Yucel & Lubman 2007; Etkin, Egner, & Kalisch
2011; Sheth et al. 2012; Shenhav et al. 2013).
Cue-elicited ACC response has previously been observed
Table 2 Mean and standard deviation of the z-scores derived
from Fisher’s z-transformation of correlation coefﬁcients
obtained from the ROI/subjective rating time course correla-
tional analysis.
Correlations
(scale-ROI)
Mean (SD)
z-score
t(df) p-value
OD: Craving-left
amygdala
0.44 (0.66) 2.40(12) 0.034*
OD: Craving-dACC 0.32 (0.71) 1.64(12) 0.126
OD: Anxiety-left
amygdala
0.15 (0.34) 1.56(13) 0.143
OD: Anxiety-dACC 0.34 (0.99) 1.29(13) 0.220
HC: Anxiety-dACC 0.006 (0.92) 0.02(8) 0.99
Table shows the t-values obtained from one-sample t-tests and corre-
sponding statistical signiﬁcance. *Signiﬁcant at p < 0.05.
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in cocaine-dependent individuals viewing a short (<5 mi-
nutes) cocaine video (Wexler et al. 2001), and positive
correlations between ACC activity and craving have been
reported (Kuhn & Gallinat 2011; Li et al. 2012). However,
traditional fMRI designs typically do not allow separation
of the generation of craving from attempts to control
craving (Goldstein & Volkow 2011). Here, our time
course analysis showed that the dACC was not signiﬁ-
cantly recruited during the video when craving was at
its peak, but was engaged after the end of the video whilst
craving was declining. This suggests that the dACC is not
involved in the generation of craving, but may be
recruited as newly abstinent individuals consciously at-
tempt to bring craving under control. Indeed, nicotine
craving studies have demonstrated that the dACC is
recruited when participants ‘resist’ (Brody et al. 2007),
or cognitively reappraise (Zhao et al. 2012), craving. Of
particular interest here, it has been demonstrated previ-
ously that opioid users show inefﬁcient dACC activation
during inhibitory control (Yucel et al. 2007), which
may reduce their ability to resist craving, and increase
risk of relapse following detoxiﬁcation. Future research
should explore the relationship between dACC response
in a newly abstinent group and duration of abstinence.
Ventral medial prefrontal cortex, the ventral striatum and
craving
Against expectations, we did not observe signiﬁcant
group or time effects for BOLD signal within the VmPFC
and ventral striatum. The VmPFC is involved in the valu-
ation of conditioned stimuli, signalling the subjective
value of associated rewards (Elliott et al. 2008;
Schoenbaum et al. 2009). VmPFC activation to drug cues
has previously been observed, but typically in non-treat-
ment-seeking individuals (Chase et al. 2011), suggesting
that the lack of signiﬁcant VmPFC recruitment in the
current study may reﬂect altered motivational salience
of drug cues in this newly abstinent group. It may also
be possible that the vulnerability of the VmPFC to suscep-
tibility artefact precluded the detection of signiﬁcant
VmPFC ﬁndings.
Extensive evidence implicates the ventral striatum in
various aspects of reward processing (Haber & Knutson
2010) including reward prediction (O’Doherty et al.
2004) and goal-directed action based on salient affective
information (Corbit, Muir, & Balleine 2001; Corbit &
Balleine 2011). It is therefore considered an important
substrate of substance dependence, and we hypothesized
that we would observe ventral striatum responses to the
drug cue video; however, no such response was observed.
As we argued for the VmPFC, this may relate to reduced
motivational salience of cues in actively treated individ-
uals in combination with increased engagement of
cognitive control processes that have been shown to
inhibit both VmPFC and ventral striatal response to drug
cues (Volkow et al. 2010). However, meta-analyses of pre-
vious fMRI studies report ventral striatum responses to
drug cues in both treatment and non-treatment-seeking
cohorts (Chase et al. 2011). Ventral striatal response to
craving cues has also been observed in another study of
inpatient detoxiﬁed opioid-dependent individuals (Li
et al. 2012). However, it is important to consider the
reasons why people are in treatment. Drug detoxiﬁcation
is often compulsory in some countries (Werb et al. 2016)
or may be ‘coerced’ (e.g. treatment to reduce or avoid a
prison sentence); therefore, being ‘in treatment’ does
not necessarily equate to ‘treatment seeking’. Different
responses to drug cues may be expected in those who
have voluntarily chosen treatment compared with those
who have been compelled or coerced to enter treatment
programmes. Furthermore, the exact stage of treatment
may inﬂuence brain response to drug cues. In the current
study, although 39 participants enrolled, approximately
50 percent self-discharged from the detoxiﬁcation unit
before the fourth week of the residential stay when scan-
ning took place. Therefore, it remains possible that our
group, tested during the last week of a voluntary, recov-
ery focussed inpatient treatment programme, represents
a distinct ‘treatment-seeking’ population maximally
motivated to maintain abstinence. Longitudinal studies
are needed to test hypotheses about differential responses
to drug cues at different stages of dependence, treatment
and abstinence (Jasinska et al. 2014).
Limitations
There are a number of limitations of this study. Most of
the OD group were still receiving psychoactive medica-
tions (Supporting Information Table S1). The limited
numbers of participants did not allow exploration of the
inﬂuence of medication; however, given its high preva-
lence within this population (Torrens, Gilchrist, &
Domingo-Salvany 2011; Vogel et al. 2013), inclusion of
these individuals allows for a more representative study
sample. Half of the OD participants were still receiving
the opioid withdrawal medication lofexidine, and one
small study reported that high doses of lofexidine
(2.4 mg twice daily) reduce craving (Sinha et al. 2007).
However, lofexidine is not generally considered to sup-
press psychological cravings (Gish et al. 2010), and a
much lower dose was administered to participants at
the point of their participation in the present study
(0.2 mg twice daily). Furthermore, differences in IQ and
years of education between our groups may have inﬂu-
enced ﬁndings. However, a particular strength to the
study was our selection of healthy volunteers based upon
occupational experience of drug use. We chose to
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prioritize this over matching for educational perfor-
mance, which ﬁndings from our group suggest do not
impact upon incentive motivation and reward processes
(Bland et al. 2016).
Another limitation was that study numbers were
relatively small, largely because this is a difﬁcult group
to recruit, especially given recent changes in UK addic-
tion service provision (the inpatient unit admission
criteria changed during the period of recruitment such
that only those with complex health needs were admit-
ted, resulting in many patients being ineligible for the
study). This may have had an impact on results; e.g. the
time course in the VmPFC did not reach signiﬁcance
because of high variability in this region prone to signal
dropout. In a larger sample, this ﬁnding might have
reached signiﬁcance.
CONCLUSION AND CLINICAL
IMPLICATIONS
Using a novel paradigm investigating dynamic brain and
craving responses, we have demonstrated a similar time
course that links the left amygdala with the emergence
of subjective craving, suggesting a craving generative role
for the amygdala. Amygdala response to drug cues may
represent a persistent vulnerability to relapse within this
cohort. By analysing brain and craving responses after
the end of the craving video, we found increased dACC
BOLD response only during the period of decreasing sub-
jective craving. This suggests a role for the dACC in
behavioural/cognitive control in recovering individuals
following a period of cue-induced craving. Persistent
amygdala activation and craving in response to drug
cues, together with inefﬁcient dACC-mediated control,
may contribute to relapse following treatment. Promising
cognitive and pharmacological treatments have been
shown to reduce amygdala cue reactivity and increase
dACC activity in both preclinical models and human tests
of cognitive performance (Spence et al. 2005; Xue et al.
2012). Our time course-based approach may represent
an important biomarker for evaluating these treatments
in dependent individuals.
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